Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Biochim Biophys Acta. 2011 Jan 15;1812(4):480–487. doi: 10.1016/j.bbadis.2011.01.005

Figure 2.

Figure 2

Biliverdin reductase-A total phosphorylation levels in hippocampus of Alzheimer disease (AD) subjects. Representative 1D gel image of immunoprecipitated BVR-A stained for total phosphorylation (Pro-Q Diamond) and for protein levels level (Sypro Ruby) in control and AD hippocampus.

HHS Vulnerability Disclosure